Béhé M - Search Results

1

Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.

Behr TM, Jenner N, Béhé M, Angerstein C, Gratz S, Raue F, Becker W. Behr TM, et al. Among authors: behe m. J Nucl Med. 1999 Jun;40(6):1029-44. J Nucl Med. 1999. PMID: 10452322 Free article.

2

Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.

Behr TM, Béhé MP. Behr TM, et al. Among authors: behe mp. Semin Nucl Med. 2002 Apr;32(2):97-109. doi: 10.1053/snuc.2002.31028. Semin Nucl Med. 2002. PMID: 11965605 Review.

3

Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.

Béhé M, Behr TM. Béhé M, et al. Biopolymers. 2002;66(6):399-418. doi: 10.1002/bip.10356. Biopolymers. 2002. PMID: 12658727

4

Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.

Béhé M, Becker W, Gotthardt M, Angerstein C, Behr TM. Béhé M, et al. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1140-6. doi: 10.1007/s00259-003-1178-1. Epub 2003 May 24. Eur J Nucl Med Mol Imaging. 2003. PMID: 12768330 Clinical Trial.

5

Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

Béhé M, Kluge G, Becker W, Gotthardt M, Behr TM. Béhé M, et al. J Nucl Med. 2005 Jun;46(6):1012-5. J Nucl Med. 2005. PMID: 15937313 Free article.

6

Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin.

Behr TM, Jenner N, Radetzky S, Béhe M, Gratz S, Yücekent S, Raue F, Becker W. Behr TM, et al. Among authors: behe m. Eur J Nucl Med. 1998 Apr;25(4):424-30. doi: 10.1007/s002590050241. Eur J Nucl Med. 1998. PMID: 9553173

7

Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.

Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W. Behr TM, et al. Among authors: behe m. Clin Cancer Res. 1999 Oct;5(10 Suppl):3124s-3138s. Clin Cancer Res. 1999. PMID: 10541353

8

Diagnostic applications of radiolabeled peptides in nuclear endocrinology.

Behr TM, Béhé M, Becker W. Behr TM, et al. Among authors: behe m. Q J Nucl Med. 1999 Sep;43(3):268-80. Q J Nucl Med. 1999. PMID: 10568142 Review.

9

Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.

Behr TM, Béhé M, Löhr M, Sgouros G, Angerstein C, Wehrmann E, Nebendahl K, Becker W. Behr TM, et al. Among authors: behe m. Eur J Nucl Med. 2000 Jul;27(7):753-65. doi: 10.1007/s002590000272. Eur J Nucl Med. 2000. PMID: 10952487

10

Imaging tumors with peptide-based radioligands.

Behr TM, Gotthardt M, Barth A, Béhé M. Behr TM, et al. Among authors: behe m. Q J Nucl Med. 2001 Jun;45(2):189-200. Q J Nucl Med. 2001. PMID: 11476170 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters